Home/Filings/4/0001209191-18-014937
4//SEC Filing

Driscoll Martin J 4

Accession 0001209191-18-014937

CIK 0001566373other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:01 PM ET

Size

4.5 KB

Accession

0001209191-18-014937

Insider Transaction Report

Form 4
Period: 2018-02-28
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2018-02-28$12.83/sh+1,000$12,83056,400 total

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001339402

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:01 PM ET
Size
4.5 KB